Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC)

Clinical trial NCT01654861 · TERMINATED

Trial details

NCT number: NCT01654861
Sponsor: Eastern Regional Medical Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Adenocarcinoma of the Pancreas

Start date: 2012-06-01
Primary completion: 2014-06-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.